All reports
All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
- 2004 (1) Apply 2004 filter
- 2006 (1) Apply 2006 filter
- 2007 (1) Apply 2007 filter
- 2008 (2) Apply 2008 filter
- 2010 (3) Apply 2010 filter
- 2011 (3) Apply 2011 filter
- 2012 (1) Apply 2012 filter
- 2013 (1) Apply 2013 filter
- 2014 (1) Apply 2014 filter
- 2016 (1) Apply 2016 filter
- 2019 (2) Apply 2019 filter
- 2020 (1) Apply 2020 filter
- Biological and genetic diagnostic tests (2) Apply Biological and genetic diagnostic tests filter
- Drugs (5) Apply Drugs filter
- Ear, nose and throat (1) Apply Ear, nose and throat filter
- Endocrine diseases, diabetes and liver diseases (5) Apply Endocrine diseases, diabetes and liver diseases filter
- Geriatrics and chronic diseases (1) Apply Geriatrics and chronic diseases filter
- Hematology and transfusion (2) Apply Hematology and transfusion filter
- (-) Remove Infectious diseases filter Infectious diseases (18)
- Pediatrics (5) Apply Pediatrics filter
- Prevention, Screening and vaccination (9) Apply Prevention, Screening and vaccination filter
- Respiratory diseases (1) Apply Respiratory diseases filter
- Skin and connective tissue diseases (1) Apply Skin and connective tissue diseases filter
- Urology and kidneys (1) Apply Urology and kidneys filter
-
[Antibiotics use in hospitals for acute pyelonephritis]
KCE Reports 3 (2004)
-
Antiviral agents in seasonal and pandemic influenza. Literature study and development of practice guidelines
KCE Reports 49 (2006)
-
Cost-effectiveness analysis of rotavirus vaccination of Belgian infants
KCE Reports 54 (2007)
-
Nosocomial Infections in Belgium, part 1: national prevalence study
KCE Reports 92 (2008)
-
[Evaluation of universal and targeted hepatitis A vaccination programs in Belgium]
KCE Reports 98 (2008)
-
Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study
KCE Reports 127 (2010)
-
[Indemnification of the victims who contracted HIV or hepatitis C through a contaminated blood transfusion]
KCE Reports 134 (2010)
-
[Cost-utility of Vaccination against Chickenpox in Children and against Herpes Zoster in Elderly in Belgium]
KCE Reports 151 (2010)
-
Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood
KCE Reports 155 (2011)
-
Seasonal influenza vaccination: priority target groups – Part I
KCE Reports 162 (2011)
-
[Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]
KCE Reports 157 (2011)
-
[Hepatitis C: Screening and Prevention]
KCE Reports 173 (2012)
-
Seasonal influenza vaccination: prioritizing children or other target groups? - Part II
KCE Reports 204 (2013)
-
A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study
KCE Reports 231 (2014)
-
Financial compensation for persons infected by a contaminated blood transfusion – an attempt to reduce discriminations
KCE Reports 273 (2016)
-
Diagnosis and management of gonorrhoea and syphilis
KCE Reports 310 (2019)
-
Sexually Transmitted Infections in primary care consultations: development of an online tool to guide healthcare practitioners
KCE Reports 321 (2019)
-
Report on Post-intensive Care Syndrome (PICS) for general practitioners
The post-intensive care syndrome (PICS) is not specific to COVID-19. In the months after discharge, it can occur in more than half of the patients that have stayed in intensive care for a serious pathology. Given the current COVID-19 pandemic, it is very likely that its incidence will increase in the coming months. PICS can cause three types of symptoms: physical (extreme muscle weakness), psychological (anxiety, depression, post-traumatic stress disorder), and cognitive (memory loss, loss of verbal fluency, attention and executive functioning disorders).